Literature DB >> 13459253

Extreme slowing of nerve conduction in peroneal muscular atrophy.

R W GILLIATT, P K THOMAS.   

Abstract

Entities:  

Keywords:  NERVES, ULNAR; PROGRESSIVE MUSCULAR ATROPHY/physiology

Mesh:

Year:  1957        PMID: 13459253     DOI: 10.1093/rheumatology/4.3.104

Source DB:  PubMed          Journal:  Ann Phys Med        ISSN: 0365-5547


× No keyword cloud information.
  14 in total

1.  Clinical electrodiagnosis.

Authors:  A T RICHARDSON
Journal:  Proc R Soc Med       Date:  1962-11

2.  On the fringes of electrodiagnosis.

Authors:  P BAUWENS
Journal:  Proc R Soc Med       Date:  1958-09

3.  Recent advances in the clinical electrophysiology of muscle and nerve.

Authors:  P K THOMAS
Journal:  Postgrad Med J       Date:  1961-07       Impact factor: 2.401

4.  [Function tests of peripheral nerves in experimental polyneuritis and in wallerian degeneration].

Authors:  H E KAESER
Journal:  Dtsch Z Nervenheilkd       Date:  1962

5.  Sensory nerve action potentials in patients with peripheral nerve lesions.

Authors:  R W GILLIATT; T A SEARS
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-05       Impact factor: 10.154

6.  [Friedreich's ataxia with peripheral nerve involvement resembling peroneal muscular atrophy].

Authors:  H C Hopf; F K Port
Journal:  Dtsch Z Nervenheilkd       Date:  1968

7.  Motor nerve conduction velocity in peroneal muscular atrophy: evidence for genetic heterogeneity.

Authors:  P K Thomas; D B Calne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-01       Impact factor: 10.154

8.  Double charcot's disease.

Authors:  F E Bruckner
Journal:  Br Med J       Date:  1968-06-08

Review 9.  Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease.

Authors:  D Pareyson; V Scaioli; M Laurà
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 10.  Intermediate forms of Charcot-Marie-Tooth neuropathy: a review.

Authors:  Garth Nicholson; Simon Myers
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.